Department of Microbiology & Immunology, Emory University School of Medicine, Atlanta, GA, 30322, USA.
Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, 30303, USA.
Mucosal Immunol. 2018 Jul;11(4):1071-1078. doi: 10.1038/s41385-018-0003-x. Epub 2018 Feb 16.
Resident memory CD8 T (T) cells in the lung parenchyma (LP) and airways provide heterologous protection against influenza virus challenge. However, scant knowledge exists regarding factors necessary to establish and maintain lung CD8 T. Here we demonstrate that, in contrast to mechanisms described for other tissues, airway, and LP CD8 T establishment requires cognate antigen recognition in the lung. Systemic effector CD8 T cells could be transiently pulled into the lung in response to localized inflammation, however these effector cells failed to establish tissue residency unless antigen was present in the pulmonary environment. The interaction of effector CD8 T cells with cognate antigen in the lung resulted in increased and prolonged expression of the tissue-retention markers CD69 and CD103, and increased expression of the adhesion molecule VLA-1. The inability of localized inflammation alone to establish lung T resulted in decreased viral clearance and increased mortality following heterosubtypic influenza challenge, despite equal numbers of circulating memory CD8 T cells. These findings demonstrate that pulmonary antigen encounter is required for the establishment of lung CD8 T and may inform future vaccine strategies to generate robust cellular immunity against respiratory pathogens.
肺部实质(LP)和气道中的驻留记忆 CD8 T(T)细胞为流感病毒攻击提供了异源保护。然而,对于建立和维持肺部 CD8 T 所需的因素,我们知之甚少。在这里,我们证明与其他组织、气道和 LP CD8 T 建立所描述的机制相反,气道和 LP CD8 T 的建立需要在肺部识别同源抗原。系统效应 CD8 T 细胞可以响应局部炎症而短暂地被拉入肺部,但是这些效应细胞除非肺环境中存在抗原,否则无法建立组织驻留。效应 CD8 T 细胞与肺部同源抗原的相互作用导致组织保留标志物 CD69 和 CD103 的表达增加和延长,以及黏附分子 VLA-1 的表达增加。局部炎症本身无法建立肺部 T 细胞,导致异源流感病毒攻击后病毒清除减少和死亡率增加,尽管循环记忆 CD8 T 细胞数量相等。这些发现表明,肺部抗原的接触是建立肺部 CD8 T 所必需的,这可能为针对呼吸道病原体产生强大细胞免疫的未来疫苗策略提供信息。
Front Immunol. 2018-1-22
Chin Med J Pulm Crit Care Med. 2024-12-18
Cell Rep. 2024-8-27
Front Immunol. 2024-2-5
Am J Respir Crit Care Med. 2015-6-15